Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars for the treatment of cancer and autoimmune conditions (e.g., rheumatoid arthritis), as well as insulin’s, …
Owing to a large population base, the prevalence of various dermatological disorders in India is fairly high, even for uncommon disorders. Vandana Mungroo Beechoo and …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
